- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 55/07 - Salts thereof
Patent holdings for IPC class C07C 55/07
Total number of patents in this class: 90
10-year publication summary
|
4
|
9
|
14
|
9
|
9
|
6
|
9
|
7
|
6
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sanofi | 4008 |
5 |
| SABIC Global Technologies B.V. | 4279 |
4 |
| Bristol-myers Squibb Company | 4897 |
3 |
| Gilead Sciences, Inc. | 2026 |
3 |
| Avantium Knowledge Centre B.V. | 191 |
3 |
| Bloom Energy Corporation | 650 |
2 |
| Celgene Corporation | 1412 |
2 |
| Central Glass Company, Limited | 1263 |
2 |
| Heraeus Precious Metals GmbH & Co. KG | 77 |
2 |
| Modernatx, Inc. | 1258 |
2 |
| Nektar Therapeutics | 438 |
2 |
| Victoria Link Limited | 182 |
2 |
| Nuvalent, Inc. | 53 |
2 |
| Vspc Pty Ltd. | 4 |
2 |
| Merck Patent GmbH | 5840 |
1 |
| Industrial Technology Research Institute | 5011 |
1 |
| Massachusetts Institute of Technology | 10002 |
1 |
| National Taiwan University | 1212 |
1 |
| Takeda Pharmaceutical Company Limited | 2703 |
1 |
| Aldeyra Therapeutics, Inc. | 109 |
1 |
| Other owners | 48 |